Health insurance coverage expanded to Abbott’s Synagis
Published: 2009-11-06 06:57:00
Updated: 2009-11-06 06:57:00
Health insurance for Synagis (palivizumab) has been further expanded to those infants under less than 12 months after birth, suffering from congenital heart disease due to respiratory syncytial virus (RVS), according to Abbott Korea.
Previously, only those aged at less than 24 months after bir...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
